Sirt3−/− mice were more susceptible to cisplatin-induced AKI as compared to their wild-type counterparts and treatment with antioxidants restored SIRT3 expression and activity and protected against renal dysfunction in the wild-type mice but not in Sirt3−/− animals. The gene discussed is SIRT3; the disease is acute kidney injury.